How are Cardio Risk Check | Herz-Kreislauf Risiko-Test and Wechseljahre related?

The relationship between a Cardio Risk Check (cardiovascular risk test) and menopause (Wechseljahre) is not directly addressed in the provided context. Medically, menopause increases cardiovascular risk due to estrogen decline, affecting blood pressure, lipid profiles, and vascular function. A cardio risk check can be particularly relevant during this phase to identify early risk factors. However, the genetic markers mentioned in the context (e.g., CYP2C9 for warfarin dosing, CYP1A2 for caffeine, MTHFR for homocysteine, ALDH2 for alcohol metabolism, TAS2R38 for bitter taste) have no specific link to menopause. They pertain to other metabolic pathways and are not validated as menopause-specific risk markers. Therefore, the evidence for a direct connection between these particular DNA tests and menopause is unclear. A comprehensive risk assessment should include clinical parameters (blood pressure, lipids, fasting glucose) and lifestyle factors alongside genetic data. Interpretation requires medical guidance, especially during perimenopause.